BioSig Technologies (BSGM) announced that its subsidiary BioSig AI Sciences was selected to join NVIDIA Inception (NVDA), a program designed to partner with companies revolutionizing industries with advancements in artificial intelligence and data sciences. “We are thrilled to join an elite group of AI-centric technology companies leading the evolution of machine learning and AI across industries,” said Ken Londoner, Chairman, CEO and Founder of BioSig. “We believe NVIDIA Inception will help advance BioSig’s role in identifying transformational applications of AI opportunities in healthcare.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on BSGM:
- BioSig AI Sciences Selected for NVIDIA Inception Partnership Program to Support R&D Collaboration on AI Medical Device Platform for Hospitals
- BioSig Technologies joins Webull Corporate Connect
- BioSig Joins Webull Corporate Connect
- BioSig Advances Collaboration on Machine Learning and Artificial Intelligence Solutions for Healthcare
- BioSig Technologies advances collaboration on machine learning, AI solutions